- Home
- TPG vs ALKS Comparison
TPG vs ALKS Comparison
Compare TPG & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPG
- ALKS
- Stock Information
- Founded
- TPG 1992
- ALKS 1987
- Country
- TPG United States
- ALKS Ireland
- Employees
- TPG N/A
- ALKS N/A
- Industry
- TPG Investment Managers
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- TPG Finance
- ALKS Health Care
- Exchange
- TPG Nasdaq
- ALKS Nasdaq
- Market Cap
- TPG 6.6B
- ALKS 5.4B
- IPO Year
- TPG 2022
- ALKS 1991
- Fundamental
- Price
- TPG $47.71
- ALKS $33.21
- Analyst Decision
- TPG Buy
- ALKS Buy
- Analyst Count
- TPG 12
- ALKS 13
- Target Price
- TPG $62.50
- ALKS $39.50
- AVG Volume (30 Days)
- TPG 1.8M
- ALKS 1.7M
- Earning Date
- TPG 05-07-2025
- ALKS 04-30-2025
- Dividend Yield
- TPG 3.65%
- ALKS N/A
- EPS Growth
- TPG N/A
- ALKS 3.47
- EPS
- TPG N/A
- ALKS 2.17
- Revenue
- TPG $3,500,082,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- TPG N/A
- ALKS N/A
- Revenue Next Year
- TPG $20.91
- ALKS $4.37
- P/E Ratio
- TPG N/A
- ALKS $15.10
- Revenue Growth
- TPG 46.45
- ALKS N/A
- 52 Week Low
- TPG $39.18
- ALKS $22.90
- 52 Week High
- TPG $72.98
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- TPG 36.58
- ALKS 43.58
- Support Level
- TPG $49.35
- ALKS $33.22
- Resistance Level
- TPG $53.15
- ALKS $34.45
- Average True Range (ATR)
- TPG 1.82
- ALKS 0.98
- MACD
- TPG 0.48
- ALKS -0.21
- Stochastic Oscillator
- TPG 23.16
- ALKS 7.78
About TPG TPG Inc.
TPG Inc is an alternative asset firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. TPG aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment and performance of its portfolio.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.